目的 探讨芪冬颐心口服液联合黛力新治疗急性非ST段抬高型心肌梗死（NSTEMI）合并焦虑患者的临床疗效。方法 将我院心内科2018年5月至2019年5月收治的152例NSTEMI合并焦虑患者作为研究对象，随机分为实验组和对照组。实验组在NSTEMI治疗基础上给予芪冬颐心口服液联合黛力新抗焦虑治疗，对照组在NSTEMI治疗基础上给予黛力新抗焦虑治疗。将两组治疗效果进行比较。结果 ①实验组总有效率81.58%，对照组总有效率46.05%，差异有统计学意义( P< 0.05)。②治疗前后两组HAMA评分比较，实验组显著低于对照组( P＜0. 05) ；实验组治疗后与对照组治疗后HAMA评分显著降低，差异有统计学意义( P＜0. 05)。③实验组心血管事件发生率19.73%，对照组42.10%，差异有统计学意义( P＜0. 05)。结论 芪冬颐心口服液联合黛力新治疗NSTEMI合并焦虑患者的临床疗效优于单纯黛力新治疗，值得在临床推广。

Objective To investigate the clinical efficacy of Qidong Yixin oral liquid combined with Deanxit in the treatment of NSTEMI with anxiety.Method From May 2017 to May 2019, 152 patients with NSTEMI with anxiety were randomly divided into experimental group and control group. The experimental group was given Qidong Yixin oral liquid combined with Deanxit anti-anxiety treatment on the basis of NSTEMI treatment, while the control group was given Deanxit anti-anxiety treatment on the basis of NSTEMI treatment. The therapeutic effects of the two groups were compared. Result The total effective rate of the experimental group was 81.58%, which was significantly higher than that of the control group (46.05%, P < 0.05)；The HAMA scores of the experimental group and the control group decreased significantly after treatment and before treatment (P < 0.05)；the HAMA scores of the experimental group and the control group decreased significantly after treatment (P < 0.05)；The incidence of cardiovascular events in the experimental group was 19.73%, which was significantly lower than that in the control group (42.10%, P < 0.05). Conclusion The clinical efficacy of Qidong Yixin Oral Liquid combined with Deanxit in the treatment of NSTEMI with anxiety is better than that of Deanxit alone, which is worthy of clinical application.

血浆RLP- C水平与冠状动脉药物洗脱支架植入术后再狭窄的相关性研究